BCBouchra Chkirate

Bouchra Chkirate

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Bouchra Chkirate has a total of 78 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Juvenile hyaline fibromatosis caused by mutation of the ANTXR2 gene: A case report*

    by Nadia Mebrouk, Badr Sououd Benjelloun Dakhama, Yasmine Lachkar, Bouchra Chkirate, Elmostafa El Fahime, Omar Askander, Najat Lamalmi, Najlae Rhorfi, Latifa Chat, Asmaa Mdaghri Alaoui

  • Open Access

    Infantile Periarteritis Nodosa (About 5 Cases and Review of the Literature)

    by Fatima Azzahraa Yatribi, Abdelali Bentahila, Bouchra Chkirate

  • Open Access

    Aicardi-Goutières Syndrome: About a 7-Month-Old Infant

    by Fatima Azzahraa Yatribi, Khadija Mouaddine, Abdelali Bentahila, Bouchra Chkirate

    The Aicardi-Goutières syndrome is an encephalopathy characterized by an arrest of psychomotor development in the first months of life, spastic tetraplegia spastic tetraplegia, abnormal movements and acquired microcephaly. Neuroimaging reveals calcifications of the basal ganglia and cerebrospinal fluid (CSF) study shows lymphocytosis. Our patient is a 7 month old child, from a 1st degree consanguineous marriage. She presents a psychomotor delay with hypotonia, nystagmus and convulsive myoclonic seizures. Cerebral CT shows an active tri ventricular hydrocephalus with multiple parenchymal calcifications with multiple cerebral parenchymal calcifications and basal ganglia of infectious appearance. The intercritical sleep EEG was unremarkable. Ophthalmological examination, including an EPI, revealed a probable retinal dystrophy predominantly on the scopic system. Brain MRI shows a mesencephalic atrophy of the annular protuberance and increased volume of the volume of the cisterns of the posterior cerebral fossa. The dosage of interferon alpha in the CSF is increased to 113 pg /ml.

  • Open Access

    A novel single variant in the MEFV gene causing Mediterranean fever and Behçet’s disease: a case report

    by Maria Zerkaoui, Fatima Zahra Laarabi, Yousra Ajhoun, Bouchra Chkirate, Abdelaziz Sefiani

    Familial Mediterranean fever is an autoinflammatory disease of unknown etiology, characterized clinically by recurrent attacks of sudden-onset fever with arthralgia and/or thoracoabdominal pain and pathogenetically by autosomal recessive inheritance due to a mutation in the MEFV gene. Behçet’s disease is an inflammatory disease characterized by recurrent oral and genital aphthous ulcerations, uveitis, and skin lesions. Preliminarily, our literature review suggested that patients with familial Mediterranean fever who also have Behçet’s disease have only a single mutated familial Mediterranean fever gene. The MEFV gene mutation responsible for familial Mediterranean fever is probably a susceptibility factor for Behçet’s disease, particularly for patients with vascular involvement, and both disorders can occur concurrently in a patient, as in the present case. A 10-year-old girl of Moroccan origin presented to our institution for genetic consultation for genetic testing of the MEFV gene. She had fever associated with abdominal and diffuse joint pain in addition to headache. These symptoms have oriented pediatricians to familial Mediterranean fever. The evolution was marked by Behçet’s syndrome symptoms. Sanger sequencing followed by complete exome sequencing analysis of the MEFV gene for the proband mutation revealed a novel variant. We conclude that the novel single variant c.2078 T > A (p.Met693Lys) could be responsible for the association of familial Mediterranean fever and Behçet’s disease. To the best of our knowledge, this is the first report of a new variant in exon 10 of the MEFV gene in a Moroccan family. This novel variant should be listed in the MEFV sequence variant databases.


  • Open Access

    Next Generation Sequencing identifies mutations in GNPTG gene as a cause of familial form of scleroderma-like disease

    by Abdelali Zrhidri, Saadia Amasdl, Jaber Lyahyai, Hanane Elouardi, Bouchra Chkirate, Laure Raymond, Grégory Egéa, Mohamed Taoudi, Said El Mouatassim, Abdelaziz Sefiani

    Background Scleroderma is a multisystem disease, characterized by fibrosis of skin and internal organs, immune dysregulation, and vasculopathy. The etiology of the disease remains unknown, but it is likely multifactorial. However, the genetic basis for this condition is defined by multiple genes that have only modest effect on disease susceptibility. Methods Three Moroccan siblings, born from non-consanguineous Moroccan healthy parents were referred for genetic evaluation of familial scleroderma. Whole Exome Sequencing was performed in the proband and his parents, in addition to Sanger sequencing that was carried out to confirm the results obtained. Results Mutation analysis showed two compound heterozygous mutations c.196C>T in exon 4 and c.635_636delTT in exon 9 of GNPTG gene. Sanger sequencing confirmed these mutations in the affected patient and demonstrated that their parents are heterozygous carriers. Conclusion Our findings expand the mutation spectrum of the GNPTG gene and extend the knowledge of the phenotype–genotype correlation of Mucolipidosis Type III gamma. This report also highlights the diagnostic utility of Next Generation Sequencing particularly when the clinical presentation did not point to specific genes.


  • Consensus classification criteria for paediatric Behçet's disease from a prospective observational cohort: PEDBD

    by Isabelle Koné-Paut, Fahrad Shahram, Martha Darce-Bello, Luca Cantarini, Rolando Cimaz, Marco Gattorno, Jordi Anton, Michael Hofer, Bouchra Chkirate, Kenza Bouayed, et al.

    Background We aimed to describe the main features of Behçet's disease (BD) in children in the largest prospective cohort to date and to propose a classification. Methods An international expert consensus group was formed to define a data set of minimal symptoms for the inclusion of patients. Patients were entered prospectively during 66 months. Experts classified patients on a consensus basis. The concordance of two international classifications was analysed in confirmed patients with BD. Comparisons of subgroups of patients helped define consensus criteria. BD-associated clinical manifestations were also investigated in three control diseases extracted from an independent data set (Eurofever). Findings In total, 42 centres from 12 countries included 230 patients; data for 219 (M/F ratio=1) could be analysed. The experts classified 156 patients (71.2%) as having confirmed BD. Males more often than females showed cutaneous, ocular and vascular symptoms and females more often genital aphthosis. Age at disease onset and skin and vascular involvement were lower for European than non-European children. Oral aphthosis was the presenting sign for 81% (179/219) of patients. The mean delay to the second symptom was 2.9±2.2 years. International classifications were not concordant with the expert classification. Our paediatric classification contains six categories, a minimum of three signs (each in a distinct category) defining paediatric BD. Three clinical signs discriminated our cohort from the Eurofever cohorts. Interpretation We present a comprehensive description of a large cohort of patients from both European and non-European countries and propose the first classification of paediatric BD for future therapeutic trials.


  • Open Access

    Vitamin D concentrations and disease activity in Moroccan children with juvenile idiopathic arthritis

    by Ilham Bouaddi, Samira Rostom, Dalal El Badri, Asmae Hassani, Bouchra Chkirate, Redoine Abouqal, Bouchra Amine, Najia Hajjaj-Hassouni

    In addition to its important metabolic activities, vitamin D also contributes to the regulation of the immune system. The aim of this study was to assess the relationship between hypovitaminosis D and disease activity in Moroccan children with juvenile idiopathic arthritis (JIA).


  • Factors influencing the quality of life of Moroccan patients with juvenile idiopathic arthritis

    by M. Ezzahri, B. Amine, S. Rostom, D. Badri, N. Mawani, S. Gueddari, S. Shyen, M. Wabi, F. Moussa, R. Abouqal, et al.

    The aim of our study is to investigate the factors influencing the quality of life, assessed by the Pediatric Quality of Life Inventory 4.0 (PedsQL4) Generic Score Scales, in Moroccan patients with juvenile idiopathic arthritis. This is a cross-sectional study conducted between January and June 2012, covering children with juvenile idiopathic arthritis (JIA) seen at the consultations of El Ayachi Hospital and Children’s Hospital of the University Hospital of Rabat. Quality of life is assessed by the PedsQL4 which is a questionnaire composed of 23 items, completed by the child and the parent; the response to each item ranges from 0 to 100, so that higher scores indicate a better quality of life. The functional impact is assessed by the Childhood Health Assessment Questionnaire (CHAQ), and the disease activity by the number of tender and swollen joints, visual analogue scale (VAS) activity, erythrocyte sedimentation rate (ESR), and C-reactive protein. Forty-seven patients are included; the average age of the patients is 11 ± 3.35 years, and 40.4 % are females, with a median disease duration of 4 (2; 6) years. The oligoarticular form presents 26.7 %, the systemic form 24.4 %, and the enthesic form 22.2 %. The median of PedsQL4 is 80.43 (63.19; 92.93), and the median of the CHAQ is 0 (0; 1). Our study shows that some clinical and biological characteristics have significant effects on PedsQL by both parent and child reports. This study suggests that the achievement of the quality of life of our patients with JIA depends on the disease activity measured by swollen joints, the number of awakenings, parent VAS, physician VAS, patient VAS, and the ESR.


  • Open Access

    Effect of body composition on bone mineral density in Moroccan patients with juvenile idiopathic arthritis

    by Dalal El Badri, Samira Rostom, Ilham Bouaddi, Asmae Hassani, Bouchra Chkirate, Bouchra Amine, Najia Hajjaj-Hassouni

    The link between bone mass and body composition is widely recognized, but only few works were selectively performed on subjects with juvenile idiopathic arthritis. The aim of our study was to investigate the effect of body composition on bone mineral density (BMD) in Moroccan patients with juvenile idiopathic arthritis. Thirty three children with juvenile idiopathic arthritis (JIA) were included in a cross-sectional study. The diagnosis of JIA was made according to the criteria of the International League of Association of Rheumatology (ILAR). Body mass index (BMI) was calculated from the ratio of weight/height2(kg/m2). Pubertal status was determined according to the Tanner criteria. Bone status, body composition and bone mineral content (BMC) were analyzed by using dual-energy X-ray absorptiometry (DXA). BMD was assessed at the lumbar spine (L1-L4) and at total body in (g/cm2). Total body fat tissue mass (FTM) and lean tissue mass (LTM) were also analyzed by DXA and expressed in kilograms. In children, low BMD was defined as a Z-score less than -2 and osteoporosis was defined as a Z-score less than -2 with a fracture history. A cross-sectional study was conducted in 33 Moroccan patients with JIA aged between 4 and 16 years, Fat mass was not related to bone density; in contrast, BMD was positively associated to LTM in total body(r = =0.41, p= 0.04) but not in lumbar spine (r = 0.29, p= 0.17). There exist significant correlation between BMC and BMD in total body (r = 0.51, p = 0.01). This study suggests that the LTM is a determining factor of the BMD during adolescence. Other studies with a broader sample would be useful to confirm this relation.


  • Sleep and its relationship to pain, dysfunction, and disease activity in juvenile idiopathic arthritis

    by S. Shyen, B. Amine, S. Rostom, D. EL Badri, M. Ezzahri, N. Mawani, F. Moussa, S. Gueddari, M. Wabi, R. Abouqal, et al.